Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BCDA BioCardia, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.06 -0.9% | $14.81 -4.9% |
| StockIQ Score | 42D Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 33F | 13F |
| Fundamental | 42D | 35F |
| Growth | 48D+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 50C- | 50C- |
| Quality | 42D | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BioCardia (BCDA) outperforms Ascentage Pharma (AAPG) in most categories. Its investor score (55 vs. 37) and technical score (69 vs. 18) are significantly higher, showing stronger market confidence and technical strength. While growth scores are nearly equal (48 vs. 50), BCDA’s overall rating is "Moderate" compared to AAPG’s "Weak." Fundamental and valuation scores favor BCDA slightly (42 vs. 35, 50 vs. 38).
